Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance ...
Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System , a self-contained instrument that cultures, incubates, and images up ...
SEATTLE, WA / ACCESSWIRE / October 29, 2021 / EMulate Therapeutics, Inc. (EMulate) announced today its involvement in, and presentation of its pre-clinical pain results at, the 15 th Annual Pain ...
The organ-on-a-chip developer Emulate has raised $82 million to boost its offerings aimed at replicating human biology through easier-to-manage in vitro cellular models. Used in past drug development ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today announced its new colon immune cell recruitment application, enabling the most human-relevant ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond ...
Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...
Organ-on-a-chip maker Emulate has launched an upgraded offering for researchers studying inflammatory bowel disease with its tissue model that helps illustrate how immune cells are activated and ...
Emulate, Inc., a leading provider of next generation in vitro models, has launched the Zoë-CM2™ Culture Module, a second-generation Zoë instrument that is at the core of their Human Emulation System®.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results